The Food and Drug Administration authorized Pfizer’s Covid-19 vaccine for emergency use on Friday, clearing the way for millions of highly vulnerable people to begin receiving the vaccine within days.The authorization is a historic turning point in a pandemic that has taken more than 290,000 lives in the United States. With the decision, the United States becomes the sixth country — in addition to Britain, Bahrain, Canada, Saudi Arabia and Mexico — to clear the vaccine. Today, we ask the science and health reporter Donald G. McNeil Jr. what might happen next.Guest: Donald G. McNeil Jr., a science and health reporter for The New York Times.For an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. You can read the latest edition here.Background reading: Pfizer has a deal with the U.S. government to supply 100 million doses of the vaccine by next March. Under that agreement, the shots will be free to the public.The vaccines are on their way, but experts still say a difficult winter of coronavirus infection and death lies ahead.For more information on today’s episode, visit nytimes.com/thedaily
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

Nachrichten
The Daily Folgen
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Also, for more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Folgen von The Daily
2597 Folgen
-
Folge vom 14.12.2020The U.S. Approves a Vaccine
-
Folge vom 13.12.2020The Sunday Read: 'Lovers in Auschwitz, Reunited'Amid the death and desperation of the Auschwitz concentration camp, two inmates, David Wisnia and Helen Spitzer, found love.On today’s episode, the story of how they found each other — first within the camp and again, seven decades later.This story was written by Keren Blankfeld and recorded by Audm. To hear more audio stories from publishers like The New York Times, download Audm for iPhone or Android. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
-
Folge vom 11.12.2020A Guide to Georgia’s Senate RunoffsIn three weeks, an election will take place that could be as important as the presidential vote in determining the course of the next four years.The Jan. 5 runoff elections in Georgia will determine whether two Republican senators, David Perdue and Kelly Loeffler, keep their seats. If their Democratic challengers, Jon Ossoff and the Rev. Raphael Warnock, both win, Democrats would claim control of the Senate, giving President-Elect Joe Biden expanded power to realize his policy agenda.Today, we offer a guide to the two Senate races in Georgia.Guest: Astead W. Herndon, a national political reporter for The New York Times.For an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. You can read the latest edition here.Background reading: In the runoffs, Republicans are focusing attacks on the Rev. Raphael Warnock, portraying him as radical, a claim he has rejected.Some Atlanta suburbs that used to be “blood red” went blue in November. After helping deliver the presidency to Democrats, we examined whether they might give them the Senate, too.For more information on today’s episode, visit nytimes.com/thedaily Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
-
Folge vom 10.12.2020Why Did the U.S. Turn Down Vaccine Doses?From the start of the pandemic, the Trump administration said it was committed to ordering and stockpiling enough potential vaccine doses to end the outbreak in the United States as quickly as possible.But new reporting from The Times has revealed that Pfizer, the maker of the first vaccine to show effectiveness against the coronavirus, tried unsuccessfully to get the government to lock in 100 million extra doses.Today, we investigate how the Trump administration missed that opportunity and what the repercussions might be.Guest: Sharon LaFraniere, an investigative reporter for The New York Times.For an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. You can read the latest edition here.Background reading: U.S. officials had the opportunity to secure enough doses of Pfizer’s coronavirus vaccine to inoculate most of the country — at no upfront cost to the government. Instead, they turned down the offer.With a smaller-than-expected order from the United States, Pfizer turned to fulfilling orders from other countries, like Britain, which began vaccinating people this week. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.